Ignite Creation Date:
2024-05-05 @ 11:53 PM
Last Modification Date:
2024-10-26 @ 10:41 AM
Study NCT ID:
NCT01442792
Status:
COMPLETED
Last Update Posted:
2022-06-23
First Post:
2011-08-18
Brief Title:
Exploring the Efficacy and Safety of Rivaroxaban to Support Elective Percutaneous Coronary Intervention
Sponsor:
Organization:
Bayer